Study on the Antitumor Effect and Glycolysis of Andrographolide in Anaplastic Thyroid Carcinoma

Ke Yang; Ke Wu; Jianguo Feng; Ling Yutian; Xin Zhu; Dong Xu

doi:10.1155/2021/5526581

Study on the Antitumor Effect and Glycolysis of Andrographolide in Anaplastic Thyroid Carcinoma

Evid Based Complement Alternat Med. 2021 Jul 14:2021:5526581. doi: 10.1155/2021/5526581. eCollection 2021.

Authors

Ke Yang^{1

2}, Ke Wu¹, Jianguo Feng¹, Ling Yutian¹, Xin Zhu^{1

2}, Dong Xu^{1

2}

Affiliations

¹ The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
² Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang 310022, China.

Abstract

Objective: To investigate the antitumor effect of andrographolide on the ATC cell lines 8505C and CAL62 and to explore the possible mechanism of the effect.

Methods: CCK8 and colony formation assays were performed to detect proliferation. Cell migration was tested by scratch assay. Annexin V/PI staining was used to detect cell apoptosis and cell cycle. Glucose and lactic acid kits were carried out to evaluate the glycolysis level after andrographolide treatment. Western blot was used to detect the changes in the apoptosis-related proteins and glycolysis-related enzymes in both 8505C and CAL62 cells.

Results: Treatment with 60 μM andrographolide had significant effects on 8505C and CAL62, including inhibition of proliferation, inhibition of migration, arrest of the cell cycle, promotion of apoptosis, and inhibition of glycolysis.

Conclusion: Andrographolide has an antitumor effect and can significantly affect glycolysis in ATC cells.